NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)

Coveler A., Skolariki A., Ciombor KK., Jourdier HM., Graham J., Peters ML., Cohen SA., Myers M., Oelmann EM., Bloss J., Blagden SP., De Gramont A., Berlin JD., Evans TRJ.

DOI

10.1016/j.annonc.2022.07.492

Type

Conference paper

Publication Date

2022-01-01T00:00:00+00:00

Volume

33

Pages

S697 - S698

Permalink More information Close